Cohort Dashboard
GP2’s mission is to further understand the genetic architecture of Parkinson’s disease (PD) through genotyping diverse participant groups and studying highly suspected monogenic forms of PD. In support of this mission, we continue to collect diverse cohorts from around the world through collaboration and openly sharing data, processes, and results. Explore the dashboard below to understand our milestones achieved so far, and continue to visit this page as data will be updated monthly.
Total Global Data
Last Updated: September 6, 2024 | Original design by GP2 Hackathon 2021 Team: Mary Makarious, Kajsa Brolin, Yeajin Song, and Anastasia Illarionova
PPMI - Oregon Health Sciences University
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
PPMI - Parkinson's Disease and Movement Disorders Center of Boca Raton
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
PPMI - Tel Aviv Sourasky Medical Center
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
PPMI - The Parkinson's Institute
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
PPMI - University of Alabama Birmingham
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
PPMI - University of California San Diego
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
PPMI - University of Cincinnati
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
PPMI - University of Pennsylvania
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
PPMI - University of Rochester
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
PPMI - University of South Florida
Number of Samples Completed and Expected
PD Samples
PD Samples
PD samples include clinically diagnosed cases that meet classifying criteria.
Non-PD Samples
Non-PD Samples
Non-PD samples include healthy controls, Prodromal, and Parkinson’s Adjacent Disorders (PAD) which come from related diagnoses and neurological disorders.
Total Samples
Total Samples
Total samples include PD cases, healthy controls, Prodromal cases, and Parkinson’s Adjacent Disorders (PAD).
